| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q2FWH6 (KDPE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcriptional regulatory protein KdpE; | |
| Q2FWF8 (SCED_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable transglycosylase SceD; | |
| Q2G2Y0 (SSL7_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Staphylococcal superantigen-like 7; | |
| Q2FWJ9 (ILVA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | L-threonine dehydratase biosynthetic IlvA; Threonine deaminase; | |
| Q2FVD5 (Y2778_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized oxidoreductase SAOUHSC_02778; | |
| Q2G1N0 (SBND_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Staphyloferrin B transporter; | |
| Q2G0D0 (Y675_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable transcriptional regulatory protein SAOUHSC_00675; | |
| Q2FXC7 (SPLE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Serine protease SplE; | |
| Q2G002 (AROD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 3-dehydroquinate dehydratase; Type I DHQase; Type I dehydroquinase; | |
| Q2G1C0 (TARI1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribitol-5-phosphate cytidylyltransferase 1; | |
| Q2G2C4 (TARI2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribitol-5-phosphate cytidylyltransferase 2; | |
| Q2FYN7 (DAPH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase; Tetrahydrodipicolinate N-acetyltransferase; | |
| Q2FUQ4 (RSMG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosomal RNA small subunit methyltransferase G; 16S rRNA 7-methylguanosine methyltransferase; | |
| Q2G1U5 (MECA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Adapter protein MecA; | |
| Q2FXC5 (SPLD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Serine protease SplD; | |
| Q2FXC4 (SPLC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Serine protease SplC; | |
| Q2FXC8 (SPLF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Serine protease SplF; | |
| P60639 (CIDB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Holin-like protein CidB; | |
| Q2FWG0 (TENA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Aminopyrimidine aminohydrolase; Thiaminase II; | |
| Q2G2K7 (UREF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Urease accessory protein UreF; | |
| Q2FXM0 (Y1815_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0173 metal-dependent hydrolase SAOUHSC_01815; | |
| Q2FXX8 (MTNN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase; 5'-deoxyadenosine nucleosidase; 5'-methylthioadenosine nucleosidase; S-adenosylhomocysteine nucleosidase; | |
| Q2FVK8 (GPMA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase; | |
| Q2G0P2 (NUSG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcription termination/antitermination protein NusG; | |
| Q2FV60 (CRTN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 4,4'-diapophytoene desaturase (4,4'-diaponeurosporene-forming); Dehydrosqualene desaturase; | |
| Q2FYU7 (CATA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Catalase; | |
| Q2G2P7 (HUTH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Histidine ammonia-lyase; | |
| Q2G212 (MNHD2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative antiporter subunit mnhD2; Mrp complex subunit D2; Putative NADH-ubiquinone oxidoreductase subunit mnhD2; | |
| Q2FYZ5 (GLPK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycerol kinase; ATP:glycerol 3-phosphotransferase; Glycerokinase; | |
| Q2FVH6 (FLP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Protein flp; FmtA-like protein; | |
| Q2G2H7 (MNHD1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Na(+)/H(+) antiporter subunit D1; Mnh complex subunit D1; | |
| Q2FZ21 (RRF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosome-recycling factor; Ribosome-releasing factor; | |
| Q2FUT1 (Y3020_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0397 protein SAOUHSC_03020; | |
| P0A086 (MSRA2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptide methionine sulfoxide reductase MsrA 2; Peptide-methionine (S)-S-oxide reductase 2; | |
| Q2FXP9 (IF3_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Translation initiation factor IF-3; | |
| Q2FUX3 (ISAB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Immunodominant staphylococcal antigen B; | |
| Q2FXU0 (APT_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Adenine phosphoribosyltransferase; | |
| Q2G2F8 (ATPF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP synthase subunit b; ATP synthase F(0) sector subunit b; ATPase subunit I; F-type ATPase subunit b; | |
| Q2FUW4 (ASP2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Accessory Sec system protein Asp2; Accessory secretory protein Asp2; | |
| Q2FW21 (RL6_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein uL6; 50S ribosomal protein L6; | |
| Q2G0T1 (RNM5_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribonuclease M5; RNase M5; Ribosomal RNA terminal maturase M5; | |
| Q2FWD0 (RPOE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable DNA-directed RNA polymerase subunit delta; RNAP delta factor; | |
| Q2FVX9 (MOAC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Cyclic pyranopterin monophosphate synthase; Molybdenum cofactor biosynthesis protein C; | |
| Q2FZ79 (LSPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Lipoprotein signal peptidase; Prolipoprotein signal peptidase; Signal peptidase II; | |
| Q2G178 (ESSG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Type VII secretion system protein EsaG; | |
| Q2G0M6 (ARAB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribulokinase; | |
| Q2G247 (Y1855_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0478 protein SAOUHSC_01855; | |
| P02976 (SPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Immunoglobulin G-binding protein A; Staphylococcal protein A; | |
| Q2FWK3 (LEU1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-isopropylmalate synthase; Alpha-IPM synthase; Alpha-isopropylmalate synthase; | |
| Q2FV67 (ROCA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 1-pyrroline-5-carboxylate dehydrogenase; L-glutamate gamma-semialdehyde dehydrogenase; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_03 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 2,889 | 2,425 | 3,847 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 16-mer | 24-mer | 25-mer | 40-mer | 60-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,426 | 986 | 79 | 209 | 8 | 75 | 6 | 15 | 3 | 8 | 14 | 2 | 5 | 1 | 7 | 1 | 1 | 1 |
